Article

PhysIOL launches new aspheric lenses

PhysIOL today announced the European launch of its aspheric aberration-correcting intraocular lenses - Slim AY 123 in a preloaded system and Micro AY for injection through a 1.8mm microincision.

PhysIOL today announced the European launch of its aspheric aberration-correcting intraocular lenses - Slim AY 123 in a preloaded system and Micro AY for injection through a 1.8mm microincision.

The lenses feature Blue Tech, PhysIOL's balanced blue-light filtration, to improve contrast sensitivity and preserve depth of field. The one-piece lenses are made in a hydrophilic acrylic material with 25% water content, combining softness with resistance to tear. They have a 6.15 mm optical diameter, the biggest optic offered in the microincison marketplace according to Global Marketing Director for PhysIOL, Mrs Elisabeth Moreau.

"Our aspheric lenses with blue blocker are available for microincision and in a pre-loaded system, " said Moreau. "We are almost the only company offering all these features in the one. "

Moreau says PhysIOL has had excellent feedback following the earlier launch of the microincision version, introduced in France at May's meeting of the French Society of Ophthalmology.

"The surgeons are very happy with the results. They appreciate the quality of the lens material. It is very resistant - something you need when you inject through a microincision - but also very soft. When the surgeons press on the injector they do not need to exert a lot of pressure and the lens unfolds very gently into the capsule bag. "

Moreau says the features of PhysIOL's aspheric lenses are complimentary in terms of quality of vision. "The blue blocker is for protection of the retina, but it also preserves quality of vision. It's all about quality of vision. "

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.